Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2024-07-23 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains the standard header information for a London Stock Exchange regulatory announcement. The content details a 'TR-1: Standard form for notification of major holdings' concerning an acquisition of voting rights by 'Slater Investments' in 'ALLIANCE PHARMA PLC', crossing a threshold (11.040000%). This type of filing, which reports changes in significant share ownership, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-07-23 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details changes in voting rights held by a shareholder ('Slater Investments') crossing a notification threshold, referencing specific regulatory fields like DTR5.1 and DTR5.3.1R. This structure is characteristic of insider trading or major shareholder transaction reporting, which falls under Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the notification is about a change in major shareholding (crossing 11.04% to 12.00%), the most appropriate classification is Major Shareholding Notification (MRQ). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it Director's Dealing (DIRS) as it concerns an investment firm/shareholder, not necessarily a director's personal transaction, although there is overlap. MRQ is the best fit for reporting changes in significant ownership levels.
2024-07-23 English
Senior Management and Board Update
Board/Management Information Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number: 3654X) on July 23, 2024. The title is "Senior Management and Board Update," and the content explicitly states that the Chief Operating Officer (COO), Jeyan Heper, will be leaving the business. This directly corresponds to the definition of Board/Management Information, which covers announcements of changes in senior management. Therefore, the appropriate code is MANG.
2024-07-23 English
Group of companies' accounts made up to 2023-12-31
Regulatory Filings
2024-07-04 English
Annual Report and Notice of AGM
Report Publication Announcement Classification · 100% confidence The document is a regulatory announcement (RNS Number: 0167V) dated July 3, 2024. It explicitly states that the 'Annual Report & Accounts for the year ended 31 December 2023' was published on June 19, 2024, and separately announces that the 'Notice of the 2024 Annual General Meeting' has been made available. Since the document itself is not the full Annual Report (10-K) or the full AGM presentation (AGM-R), but rather an announcement confirming the publication of these documents and the AGM notice, it fits the definition of a Report Publication Announcement (RPA). The document is short and serves to inform the market about the availability of other official reports.
2024-07-03 English
Block Listing Six Monthly Return
Remuneration Information Classification · 99% confidence The document is identified by the header 'RNS Number : 8098U' and contains information typical of a regulatory filing disseminated via the London Stock Exchange's RNS service. The content specifically details a 'Block Listing Six Monthly Return' covering the period from December 28, 2023, to June 28, 2024, concerning the allotment and balance of securities under various share option plans. This type of routine update regarding the issuance/allotment of shares under existing schemes, reported periodically, does not fit neatly into the specific categories like 10-K, ER, or DIV. Since it is a formal regulatory announcement distributed via RNS, and it is not a general announcement (RPA) but a specific compliance filing, the most appropriate general regulatory category is RNS, as it is a miscellaneous regulatory filing that doesn't match the other specific codes. It is not a Share Issue/Capital Change (SHA) because it is reporting on the status of previously authorized block listings/options, not a primary capital change announcement.
2024-07-02 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.